Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Synta66 is a store-operated calcium entry channel Orai inhibitor, and used for the research of neurological disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 33.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 128.00 | |
25 mg | In stock | $ 263.00 | |
50 mg | In stock | $ 422.00 | |
100 mg | In stock | $ 628.00 | |
500 mg | In stock | $ 1,350.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 89.00 |
Description | Synta66 is a store-operated calcium entry channel Orai inhibitor, and used for the research of neurological disease. |
In vitro | Synta66 is an inhibitor of Orai, which forms the pore of the CRAC channel.Synta66 (10 μM) suppresses human platelet activation in plasma and whole-blood thrombus formation. Synta66 (10 μM) inhibits LAD2 human mast cell line. |
Molecular Weight | 352.36 |
Formula | C20H17FN2O3 |
CAS No. | 835904-51-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (170.28 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Synta66 835904-51-3 Membrane transporter/Ion channel Metabolism Calcium Channel inhibit Ca2+ release-activated Ca2+ channels Calcium release-activated channels CRAC Channel Inhibitor Synta 66 Synta-66 inhibitor